Literature DB >> 23150089

[Intermediate and high risk prostate cancer patients. Clinical significance of extended lymphadenectomy].

D K Osmonov1, A Boller, A Aksenov, M Naumann, K P Jünemann.   

Abstract

INTRODUCTION: We examined the quantity and localization of pelvic lymph node (LN) metastases in patients undergoing extended pelvic lymphadenectomy (ePLND).
MATERIALS AND METHODS: A total of 174 patients with intermediate and high-risk prostate cancer underwent radical prostatectomy (RP) and ePLND. We analyzed the relationship between the number of LNs removed and the number, frequency and topography of LN metastases.
RESULTS: In group 1 (intermediate risk patients, n=115) the average number of LNs removed was 20.5, LN metastases were found in 15 patients (13 %) and the localizations were in the external iliac artery 19 %, the internal iliac artery 32 %, the obturator foramen 36 %, the common iliac artery 7 %, Marcille's triangle 3 % and sacral regions 3 %. In group 2 (high-risk patients, n=59) the average number of LNs removed was 23.9, LN metastases were found in 19 patients (32 %) and the localizations were the external iliac artery 15 %, the internal iliac artery 26 %, the obturator foramen 19 %, the common iliac artery 29 %, Marcille's triangle 6 % and sacral regions 5 %. The full number of metastases was detected only if more than 15 LNs were removed in group 1 and 18 LNs in group 2.
CONCLUSIONS: At least 15 LNs in the intermediate risk group and at least 18 LNs in high risk group should be removed. The ePLND should include the common iliac artery, the internal iliac artery, Marcille's triangle and sacral regions.

Entities:  

Mesh:

Year:  2013        PMID: 23150089     DOI: 10.1007/s00120-012-3005-4

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  19 in total

1.  Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?

Authors:  Pia Bader; Fiona C Burkhard; Regula Markwalder; Urs E Studer
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

2.  Is the number of lymph nodes removed during PLND related to the prevalence of lymph node invasion?

Authors:  Karim Touijer
Journal:  Nat Clin Pract Urol       Date:  2007-08-14

3.  Extended lymphadenectomy "step by step" in patients undergoing radical prostatectomy.

Authors:  Daniar Kurmanbekovich Osmonov; Chaojun Wang; Jorg Hoenle; Aleksej Aksenov; Claudius Hamann; Carsten Maik Naumann; Klaus Peter Juenemann
Journal:  Urology       Date:  2011-01-22       Impact factor: 2.649

4.  Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer.

Authors:  Alberto Briganti; Felix K-H Chun; Andrea Salonia; Nazareno Suardi; Andrea Gallina; Luigi Filippo Da Pozzo; Marco Roscigno; Giuseppe Zanni; Luc Valiquette; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2006-08-31       Impact factor: 20.096

5.  Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques.

Authors:  N N Stone; R G Stock; P Unger
Journal:  J Urol       Date:  1997-11       Impact factor: 7.450

6.  Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection.

Authors:  Fiona C Burkhard; Pia Bader; Eric Schneider; Regula Markwalder; Urs E Studer
Journal:  Eur Urol       Date:  2002-08       Impact factor: 20.096

7.  [Extended sentinel lymph node dissection in radical prostatectomy for prostate cancer: a study in the Kiel risk population].

Authors:  S Hautmann; S Beitz; M Naumann; U Lützen; C Seif; S H Stübinger; C van der Horst; P M Braun; I Leuschner; E Henze; K P Jünemann
Journal:  Urologe A       Date:  2008-03       Impact factor: 0.639

8.  Radical retropubic prostatectomy with reduced morbidity: an anatomic approach.

Authors:  P C Walsh
Journal:  NCI Monogr       Date:  1988

9.  Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.

Authors:  Alberto Briganti; Umberto Capitanio; Felix K-H Chun; Andrea Gallina; Nazareno Suardi; Andrea Salonia; Luigi F Da Pozzo; Renzo Colombo; Valerio Di Girolamo; Roberto Bertini; Giorgio Guazzoni; Pierre I Karakiewicz; Francesco Montorsi; Patrizio Rigatti
Journal:  Eur Urol       Date:  2008-05-21       Impact factor: 20.096

10.  Endoscopic extraperitoneal radical prostatectomy: the University of Leipzig experience of 2000 cases.

Authors:  Jens-Uwe Stolzenburg; Robert Rabenalt; Minh Do; Panagiotis Kallidonis; Evangelos N Liatsikos
Journal:  J Endourol       Date:  2008-10       Impact factor: 2.942

View more
  5 in total

1.  Significance of examined lymph-node count in accurate staging and long-term survival in patients undergoing radical prostatectomy: a population-based study.

Authors:  Cheng Chen; Jie Shen; Zhaoyu Xing; Changchuan Jiang; Linkun Hu; Li Cui; Dong Xue; Xiaozhou He; Renfang Xu
Journal:  Int Urol Nephrol       Date:  2019-09-30       Impact factor: 2.370

Review 2.  [Salvage lymphadenectomy in patients with prostate cancer recurrence: A review].

Authors:  D K Osmonov; A V Aksenov; C A Jilg; W Schultze-Seeman; C M Naumann; M F Hamann; K Bothe; K-P Jünemann
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

3.  Extended salvage pelvic lymph node dissection in patients with recurrent prostate cancer.

Authors:  Daniar K Osmonov; Alexey V Aksenov; Annkathrin Boller; Almut Kalz; Diana Heimann; Isa Janssen; Klaus-Peter Jünemann
Journal:  Adv Urol       Date:  2014-02-12

4.  Embryological Development and Topographic Anatomy of Pelvic Compartments-Surgical Relevance for Pelvic Lymphonodectomy.

Authors:  Andreas Bayer; Tillmann Heinze; Ibrahim Alkatout; Daniar Osmonov; Sigmar Stelzner; Thilo Wedel
Journal:  J Clin Med       Date:  2021-02-11       Impact factor: 4.241

5.  Applied anatomy of pelvic lymph nodes and its clinical significance for prostate cancer:a single-center cadaveric study.

Authors:  Jia-Jun Chen; Zai-Sheng Zhu; Yi-Yi Zhu; Hong-Qi Shi
Journal:  BMC Cancer       Date:  2020-04-16       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.